<big id="p71ll"><strike id="p71ll"><span id="p71ll"></span></strike></big>

      <pre id="p71ll"><ruby id="p71ll"><ol id="p71ll"></ol></ruby></pre>
      <pre id="p71ll"><ruby id="p71ll"><ruby id="p71ll"></ruby></ruby></pre>
      <noframes id="p71ll"><pre id="p71ll"><strike id="p71ll"></strike></pre>
      <noframes id="p71ll"><pre id="p71ll"></pre>

        <track id="p71ll"><ruby id="p71ll"></ruby></track>

          <noframes id="p71ll"><pre id="p71ll"><ruby id="p71ll"></ruby></pre>

            Linus Ho, M.D., Ph.D. 助理教授

            權威醫生

            出診醫院/科室: MD安德森癌癥中心 內科

            醫生介紹

            美國得克薩斯州休斯敦德克薩斯大學安德森癌癥中心腫瘤醫學科消化道(GI)腫瘤科副教授
            教育經歷:
            1991年斯坦福大學醫學院,美國加利福尼亞州斯坦福市,醫學博士
            1991年斯坦福大學醫學院,美國加利福尼亞州斯坦福市,博士,癌癥生物學
            出版物:
            1. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin oncol 26 (21) :3487-95, 2008. PMID: 18640929
            2. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin oncol 26 (21) :3496-502, 2008. PMID: 18640930
            3. Agarwal B, Correa AM, Ho L Survival in pancreatic carcinoma based on tumor size. Pancreas 36 (1) :e15-20, 2008. PMID: 18192868
            4. Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, Hruban RH, Goggins MS, Abbruzzese JL, Maitra A, Ho L Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 20 (5) :570-8, 2007. PMID: 17396143
            5. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11 (11) :1498-504; discussion 1504-5, 2007. PMID: 17849166
            6. Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, Varadhachary G, Bhat S, Wolff RA, Crane C Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. J Pain Symptom Manage 34 (3) :244-52, 2007. PMID: 17513082
            7. Ajani JA, Jiang Y, Faust J, Chang BB, Ho L, Yao JC, Rousey S, Dakhil S, Cherny RC, Craig C, Bleyer A A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma. Invest New Drugs 24 (4) :353-7, 2006. PMID: 16683077
            8. Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX Potential Role of Jun Activation Domain-Binding Protein 1 as a Negative Regulator of p27kip1 in Pancreatic Adenocarcinoma Cancer Res 66:8581-9, 2006. PMID: 16951171
            9. Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin oncol 24 (7) :1145-51, 2006. PMID: 16505434
            10. Ajani JA, Hecht JR, Ho L, Baker J, Oortgiesen M, Eduljee A, Michaeli D An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer 106 (9) :1908-16. PMID: 16568451
            11. Overman MJ, Kazmi SM, Jhamb J, Lin E, Yao JC, Abbruzzese JL, Ho L, Ajani J, Phan AWeekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer. Cancer 116 (6) :1446-53. PMID: 20108336

            Linus Ho, M.D., Ph.D. 助理教授

            MD安德森癌癥中心 內科

            擅長

            簡介

            美國得克薩斯州休斯敦德克薩斯大學安德森癌癥中心腫瘤醫學科消化道(GI)腫瘤科副教授
            教育經歷:
            1991年斯坦福大學醫學院,美國加利福尼亞州斯坦福市,醫學博士
            1991年斯坦福大學醫學院,美國加利福尼亞州斯坦福市,博士,癌癥生物學
            出版物:
            1. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin oncol 26 (21) :3487-95, 2008. PMID: 18640929
            2. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin oncol 26 (21) :3496-502, 2008. PMID: 18640930
            3. Agarwal B, Correa AM, Ho L Survival in pancreatic carcinoma based on tumor size. Pancreas 36 (1) :e15-20, 2008. PMID: 18192868
            4. Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, Hruban RH, Goggins MS, Abbruzzese JL, Maitra A, Ho L Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 20 (5) :570-8, 2007. PMID: 17396143
            5. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11 (11) :1498-504; discussion 1504-5, 2007. PMID: 17849166
            6. Reyes-Gibby CC, Chan W, Abbruzzese JL, Xiong HQ, Ho L, Evans DB, Varadhachary G, Bhat S, Wolff RA, Crane C Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation. J Pain Symptom Manage 34 (3) :244-52, 2007. PMID: 17513082
            7. Ajani JA, Jiang Y, Faust J, Chang BB, Ho L, Yao JC, Rousey S, Dakhil S, Cherny RC, Craig C, Bleyer A A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma. Invest New Drugs 24 (4) :353-7, 2006. PMID: 16683077
            8. Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX Potential Role of Jun Activation Domain-Binding Protein 1 as a Negative Regulator of p27kip1 in Pancreatic Adenocarcinoma Cancer Res 66:8581-9, 2006. PMID: 16951171
            9. Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin oncol 24 (7) :1145-51, 2006. PMID: 16505434
            10. Ajani JA, Hecht JR, Ho L, Baker J, Oortgiesen M, Eduljee A, Michaeli D An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. Cancer 106 (9) :1908-16. PMID: 16568451
            11. Overman MJ, Kazmi SM, Jhamb J, Lin E, Yao JC, Abbruzzese JL, Ho L, Ajani J, Phan AWeekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer. Cancer 116 (6) :1446-53. PMID: 20108336

            TA的文章視頻